ARL6IP5 and breast cancer: Flow cytometry analysis showed that JWA overexpression increased the percentage of cells in the G1 phase and decreased the percentage of cells in the S phase (Fig. 6F, G), indicating that JWA might inhibit the G1-to-S phase transition in trastuzumab-resistant breast cancer cells.